Adverum Biotechnologies, Inc.

Ticker ADVM

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in Redwood City, California

Adverum is a gene therapy company advancing novel medicines that can offer life-changing benefits to patients living with serious rare and ocular diseases. Adverum has a robust pipeline that includes product candidates designed to treat wet age-related macular degeneration (wAMD) and rare diseases alpha-1 antitrypsin (A1AT) deficiency and hereditary angioedema (HAE).

Visit website

Social Media Links

REPORT RATINGS

4.8 / 5.0 (218)

Adverum Biotechnologies, Inc. reports have an aggregate usefulness score of 4.8 based on 218 reviews.

Adverum Biotechnologies, Inc.

Most Recent Annual Report

MOST RECENT 2022 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Adverum Biotechnologies, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.